CD1D and neoplasm: iNKT cells have the ability to kill CD1d+ tumor cells and immune suppressive cells in the tumor microenvironment through direct cytotoxicity, but also modulate the immune response of NK cells and DCs through cytokine secretion, producing enhanced anti-tumor responses of conventional endogenous T cells (16, 19, 86).